920543
Last Update Posted: 2016-09-01
Recruiting has ended
All Genders accepted | 12 Years + |
464 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
GSK BHR Study (Sont)
The purpose of this study was to determine whether asthma control and reduced bronchial hyperresponsiveness could be achieved and maintained at a lower dose of inhaled corticosteroids with ADVAIR DISKUS twice-daily or FP twice-daily in adult and adolescent subjects with persistent asthma
Eligibility
Relevant conditions:
Asthma
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov